Anfarm Hellas S.A. - Main Component
Active Substance | Strength | Form |
---|---|---|
Ondansetron | 2mg/ml (Ampx4ml) | Inj.Sol |
Palonosetron | 250mcg/5ml | Inj.Sol |
Pantoprazole | 40mg/Vial | Pd.Inj.Sol |
PosaconazoleUnder Development | 40 mg/mL | Oral Suspension |
PosaconazoleUnder Development | 100mg/tab | G.R. tabs |
PosaconazoleUnder Development | 300 mg | C.So.In |
RemifentanilUnder Development | 1, 2 and 5 mg/vial | Pd.C.So.In |
Simvastatin | 20mg, 40mg | F.C.Tab |
Somatostatin | 3mg/Vial | Ps.Sol.Inf |
Suggamadex | 100mg/ml | Inj.Sol |
Tedizolid phosphateUnder Development | 200mg/tab | F.C. Tabs |
Tedizolid phosphateUnder Development | 200mg | Pd.C.So.In |
TeicoplaninUnder Development | 200 mg & 400 mg/vial | Pd.Sol.Inf |
Tenoxicam | 20mg/Vial | Ps.Inj.Sol |
Tenoxicam | 20mg | F.C.Tab |
Tigecycline | 50mg/Vial | Pd.Sol.Inf |
Vancomycin | 500mg/Vial | Pd.Sol.Inf |
Vancomycin | 1g/vial | Pd.Sol.Inf |
Vildagliptin/Metformin | (50+850)mg/tab & (50+1000)mg/tab | Tabs |
Voriconazole | 200mg/Vial | Pd.Sol.Inf |
Active Substance | Strength | Form |
---|---|---|
Ondansetron | 2mg/ml (Ampx4ml) | Inj.Sol |
Palonosetron | 250mcg/5ml | Inj.Sol |
Pantoprazole | 40mg/Vial | Pd.Inj.Sol |
PosaconazoleUnder Development | 40 mg/mL | Oral Suspension |
PosaconazoleUnder Development | 100mg/tab | G.R. tabs |
PosaconazoleUnder Development | 300 mg | C.So.In |
RemifentanilUnder Development | 1, 2 and 5 mg/vial | Pd.C.So.In |
Simvastatin | 20mg, 40mg | F.C.Tab |
Somatostatin | 3mg/Vial | Ps.Sol.Inf |
Suggamadex | 100mg/ml | Inj.Sol |
Tedizolid phosphateUnder Development | 200mg/tab | F.C. Tabs |
Tedizolid phosphateUnder Development | 200mg | Pd.C.So.In |
TeicoplaninUnder Development | 200 mg & 400 mg/vial | Pd.Sol.Inf |
Tenoxicam | 20mg/Vial | Ps.Inj.Sol |
Tenoxicam | 20mg | F.C.Tab |
Tigecycline | 50mg/Vial | Pd.Sol.Inf |
Vancomycin | 500mg/Vial | Pd.Sol.Inf |
Vancomycin | 1g/vial | Pd.Sol.Inf |
Vildagliptin/Metformin | (50+850)mg/tab & (50+1000)mg/tab | Tabs |
Voriconazole | 200mg/Vial | Pd.Sol.Inf |
Active Substance | Strength | Form | Market Availability |
---|---|---|---|
Ondansetron | 2mg/ml (Ampx4ml) | Inj.Sol | Selected Markets |
Palonosetron | 250mcg/5ml | Inj.Sol | International |
Pantoprazole | 40mg/Vial | Pd.Inj.Sol | International |
PosaconazoleUnder Development | 40 mg/mL | Oral Suspension | TBC |
PosaconazoleUnder Development | 100mg/tab | G.R. tabs | TBC |
PosaconazoleUnder Development | 300 mg | C.So.In | Q1 / Q2 2025 |
RemifentanilUnder Development | 1, 2 and 5 mg/vial | Pd.C.So.In | Q2 2024 |
Simvastatin | 20mg, 40mg | F.C.Tab | Selected Markets |
Somatostatin | 3mg/Vial | Ps.Sol.Inf | International |
Suggamadex | 100mg/ml | Inj.Sol | International |
Tedizolid phosphateUnder Development | 200mg/tab | F.C. Tabs | TBC |
Tedizolid phosphateUnder Development | 200mg | Pd.C.So.In | TBC |
TeicoplaninUnder Development | 200 mg & 400 mg/vial | Pd.Sol.Inf | Q1 2023 |
Tenoxicam | 20mg/Vial | Ps.Inj.Sol | International |
Tenoxicam | 20mg | F.C.Tab | Selected Markets |
Tigecycline | 50mg/Vial | Pd.Sol.Inf | International |
Vancomycin | 500mg/Vial | Pd.Sol.Inf | International |
Vancomycin | 1g/vial | Pd.Sol.Inf | International |
Vildagliptin/Metformin | (50+850)mg/tab & (50+1000)mg/tab | Tabs | International |
Voriconazole | 200mg/Vial | Pd.Sol.Inf | International |